Indications for the 2022 PMCF study

Indications from the PMCF Studies: 2022 Analysis

PMCF User Study 2019–2022 – Annual interim analysis of the ongoing study

In this year’s PMCF study, we analysed 1,834 treatments using LuXXaMed microcurrent and LED light therapy. 1,834 treatments means 1,834 questionnaires – and the use of LuXXaMed for a wide variety of indications.
Β 
In doing so, we look not only at the effects of individual treatments, but also at the areas of application, such as the muscular system, the spine, and the tendons and ligaments. The overall satisfaction of doctors, physiotherapists, alternative practitioners and occupational therapists also plays a very significant role.
Β 
After removing duplicates, the therapy was used for 9️⃣ 1️⃣ 9️⃣ different indications, although the different names given to the same indications have not been taken into account here. Nevertheless, all in all, the study participants demonstrated a very wide range of applications.
Webseminar Grundlagen β€” Webseminar Grundlagen Mikrostromtherapie und generelle Fragen.
Jetzt anmelden